Regencell Bioscience
31 hedge funds and large institutions have $16.5M invested in Regencell Bioscience in 2026 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
0.02% more ownership
Funds ownership: 0.11% → 0.13% (+0.02%)
37% less call options, than puts
Call options by funds: $1.74M | Put options by funds: $2.78M
Holders
31
Holding in Top 10
–
Calls
$1.74M
Puts
$2.78M
Top Buyers
| 1 | +$894K | |
| 2 | +$893K | |
| 3 | +$485K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$335K |
| 5 |
Legal & General Group
London,
United Kingdom
|
+$280K |
Top Sellers
| 1 | -$317K | |
| 2 | -$275K | |
| 3 | -$92.4K | |
| 4 |
Morgan Stanley
New York
|
-$38.1K |
| 5 |
QL
Quarry LP
New York
|
-$9.83K |
